19 Recruiting Solid Tumors Clinical Trials in California
Explore active solid tumors research studies enrolling across California. Verify eligibility and contact site coordinators.
📍 Find Near Me by DistanceBrowse by City
Recruiting Solid Tumors Studies in California
Study of Anti-CEACAM5 ADC M9140 in Participants With Advanced Solid Tumors (PROCEADE PanTumor)
📍 University of California - Los Angeles - 300208353 — Santa Monica, California
View Study & Checklist ➔Safety, Tolerability, and Immunogenicity of mRNA-4157 Alone and in Combination in Participants With Solid Tumors
📍 Angeles Clinic and Research Institute — Los Angeles, California
View Study & Checklist ➔A Study to Evaluate INCB177054 in Participants With Select Advanced or Metastatic Solid Tumors
📍 The Angeles Clinic and Research Institute — Los Angeles, California
View Study & Checklist ➔Study of INCB123667 in Subjects With Advanced Solid Tumors
📍 City of Hope Medical Center — Duarte, California
View Study & Checklist ➔A Study to Evaluate INCB186748 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation
📍 UCLA Healthcare Hematology-Oncology — Santa Monica, California
View Study & Checklist ➔A Study of ADRX-0706 in Select Advanced Solid Tumors
📍 USC Norris Comprehensive Cancer Center — Los Angeles, California
View Study & Checklist ➔Study Of Entrectinib (Rxdx-101) in Children and Adolescents With Locally Advanced Or Metastatic Solid Or Primary CNS Tumors And/Or Who Have No Satisfactory Treatment Options
📍 University of California San Diego — La Jolla, California
View Study & Checklist ➔DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
📍 USA06-0 — Los Angeles, California
View Study & Checklist ➔APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
📍 Cedars-Sinai Medical Center - Samuel Oschin Comprehensive Cancer Institute — Los Angeles, California
View Study & Checklist ➔A Study to Evaluate the Safety of INCA33890 in Participants With Advanced or Metastatic Solid Tumors
📍 The Angeles Clinic and Research Institute — Los Angeles, California
View Study & Checklist ➔A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies
📍 City of Hope Medical Center — Duarte, California
View Study & Checklist ➔QTX3034 in Patients With KRAS G12D Mutation
📍 UCLA Hematology/Oncology — Los Angeles, California
View Study & Checklist ➔A Study to Test How Different Doses of BI 1703880 in Combination With Ezabenlimab Are Tolerated in People With Different Types of Advanced Cancer (Solid Tumours)
📍 Valkyrie Clinical Trials — Los Angeles, California
View Study & Checklist ➔A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
📍 Local Institution - 0096 — San Francisco, California
View Study & Checklist ➔Phase 1a/b Study of ZL-6201 Safety, PK, and Preliminary Efficacy in Sarcoma and Selected Tumors
📍 Zai Lab Site 02003 — Los Angeles, California
View Study & Checklist ➔S-531011 as Monotherapy and in Combination With an Immune Checkpoint Inhibitor in Advanced or Metastatic Solid Tumors
📍 Angeles Clinic and Research Center — Los Angeles, California
View Study & Checklist ➔A Study of ZL-1310 in Participants With Selected Solid Tumors
📍 University of California San Francisco/Helen Diller Family Comprehensive Cancer Center — San Francisco, California
View Study & Checklist ➔Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration
📍 City of Hope — Duarte, California
View Study & Checklist ➔A Study of ADRX-0405 in Subjects With Select Advanced Solid Tumors
📍 City of Hope — Duarte, California
View Study & Checklist ➔